Akkiz, H., Bayram, S., Bekar, A., Akgollu, E. and Ulger, Y. 2011. A functional polymorphism in premicroRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study. – J. Viral Hepat. 18: e399–407.
Bartel D.P. 2009: MicroRNAs: target recognition and regulatory functions. – Cell 136: 215-233 .
Catucci, I., Yang, R., Verderio, P., Pizzamiglio, S., Heesen, L., Hemminki, K., Sutter, C., Wappenschmidt, B., Dick, M., Arnold, N., Bugert, P., Niederacher, D., Meindl, A., Schmutzler, R.K., Bartram, C.C., Ficarazzi, F., Tizzoni, L., Zaffaroni, D., Manoukian, S., Barile, M., Pierotti, M.A., Radice, P., Burwinkel, B. and Peterlongo, P. 2010. Evaluation of SNPs in miR146a, miR196a2 and miR 499 as low-penetrance alleles in German and Italian familial breast cancer cases. – Hum. Mutat. 31: E1052-7.
Chen, C., Zhang, Y., Zhang, L., Weakley, S.M. and Yao, Q. 2011. MicroRNA-196: critical roles and clinical applications in development and cancer. – J. Cell Mol. Med. 15: 14-23.
Dumitrescu, R.G. and Cotarla, I. 2005. Understanding breast cancer risk - where do we stand in 2005? – J. Cell Mol. Med. 9: 208-221.
Fabbri, M., Valeri, N. and Calin, G.A. 2009. MicroRNAs and genomic variations: from Proteus tricks to Prometheus gift. – Carcinogenesis 30: 912- 917.
Filipowicz, W., Bhattacharyya, S.N. and Sonenberg, N. 2008. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? – Nat. Rev. Genet. 9: 102-114.
Gao, L.B., Bai, P., Pan, X.M., Jia, J., Li, L.J., Liang, W.B., Tang, M., Zhang, L.S., Wei, Y.G. and Zhang, L. 2011. The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis. – Breast Cancer Res. Treat.125: 571-574.
Garzon, R., Calin, G.A. and Croce, C.M. 2009. microRNAs in cancer. – Annu. Rev. Med. 60:167-179 George, G.P., Gangwar, R., Mandal, R.K., Sankhwar,
S.N. and Mittal, R.D. 2011. Genetic variation in microRNA genes and prostate cancer risk in North Indian population. – Mol. Biol. Rep. 38: 1609-1615.
Hoffman, A.E., Zheng, T., Yi, C., Leaderer, D., Weidhaas, J., Slack, F., Zhang, Y., Paranjape, T. and Zhu, Y. 2009. mcroRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. – Cancer Res. 15: 5970-5979.
Hosseinzadeh, M., Eivazi Ziaei, J., Mahdavi, N., Aghajari, P., Vahidi, M., Fateh, A. and Asghari, E. 2014. Risk factors for breast cancer in Iranian women: a hospital-based case-control study in Tabriz, Iran. – J. Breast Cancer 17: 236-243.
Hu, Z., Chen, J., Tian, T., Zhou, X., Gu, H., Xu, L., Zeng, Y., Miao, R., Jin, G., Ma, H., Chen, Y. and Shen, H. 2008. Genetic variants of miRNA sequences and non-small cell lung cancer survival. – J. Clin. Invest. 118: 2600-2608.
Hu, Z., Liang, J., Wang, Z., Tian, T., Zhou, X., Chen, J., Miao, R., Wang, Y., Wang, X. and Shen. H. 2009. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. – Hum. Mutat. 30: 79-84.
Johnson, S.M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K.L., Brown, D. and Slack, F.J. 2005. RAS is regulated by the let-7 microRNA family. – Cell 120: 635-647.
Landi, D., Gemignani, F. and Landi, S. 2012. Role of variations within microRNA-binding sites in cancer. – Mutagenesis 27: 205-210.
Landi, D., Gemignani, F., Naccarati, A., Pardini, B., Vodicka, P., Vodickova, L., Novotny, J., Försti, A., Hemminki, K., Canzian, F. and Landi, S. 2008. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. – Carcinogenesis 29: 579-584.
Lewis, B.P., Burge, C.B. and Bartel, D.P. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. – Cell 120: 15-20.
Lin, P.Y. and Yang, P.C. 2011: Circulating miRNA signature for early diagnosis of lung cancer. – EMBO Mol. Med. 3: 436-437.
Linhares, J.J., Azevedo, M., Siufi, A.A., de Carvalho, C.V., Wolgien Mdel, C., Noronha, E.C., Bonetti, T.C. and da Silva, I.D. 2012. Evaluation of single nucleotide polymorphisms in microRNAs (hsa-miR-196a2 rs11614913 C/T) from Brazilian women with breast
cancer. – BMC Med. Genet. 13:119. doi: 10.1186/1471-2350-13-119.
Miller, S.A., Dykes, D.D. and Polesky, H.F. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. – Nucleic Acids Res.16: 12-15.
Mirtalebi, H., Heydari, N.M., Pourhoseingholi, M. and Asadzadeh-Aghdaei, H. 2014. Association of miR196a2 (rs11614t913) polymorphism with colorectal cancer in Tehran population. – Medical Science Journal of Islamic Azad University, Tehran Medical
Branch 23: 11-15
Mousavi, S.M., Gouya, M.M., Ramazani, R., Davanlou, M., Hajsadeghi, N. and Seddighi, Z. 2009. Cancer incidence and mortality in Iran. – Ann. Oncol.
Okubo, M., Tahara, T., Shibata, T., Yamashita, H., Nakamura, M., Yoshioka, D., Yonemura, J., Ishizuka, T., Arisawa, T. and Hirata, I. 2010. Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population.
Helicobacter 15: 524-531.
Otaghvar, H.A., Hosseini, M., Tizmaghz, A.,Shabestanipour, G.H. and Noori, H. 2015. A review on metastatic breast cancer in Iran. – Asian Pac. J. Trop. Biomed. 5: 429-433.
Sadjadi, A., Nouraie, M., Ghorbani, A., Alimohammadian, M. and Malekzadeh, R. 2009. Epidemiology of breast cancer in the Islamic Republic of Iran: first results from a population-based cancer registry. – East Mediterr. Health J. 15: 1426-1431.
Saj, A. and Lai, E.C. 2011. Control of microRNA biogenesis and transcription by cell signaling pathways. – Curr. Opin. Genet. Dev. 21: 504-510.
Shastry, B.S. 2009. SNPs: impact on gene function and phenotype. – Methods Mol. Biol. 578: 3-22.
Srivastava, K., Srivastava, A. and Mittal, B. 2010. Common genetic variants in premicroRNAs and risk of gallbladder cancer in North Indian population. – J. Hum. Genet. 55: 495-499.
Vinci, S., Gelmini, S., Pratesi, N., Conti, S., Malentacchi, F., Simi, L., Pazzagli, M. and Orlando, C. 2011. Genetic variants in miR-146a, miR-149, miR196a2, miR-499 and their influence on relative expression in lung cancers. – Clin. Chem. Lab. Med. 49: 2073-2080 .
Visone, R., Russo, L., Pallante, P., De Martino, I., Ferraro, A., Leone, V., Borbone, E., Petrocca, F., Alder, H., Croce, C.M. and Fusco, A. 2007. MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. – Endocr. Relat. Cancer 14: 791-798.
Wang, K., Guo, H., Hu, H., Xiong, G., Guan, X., Li, J., Xu, X., Yang, K. and Bai, Y. 2010. A functional variation in pre-microRNA-196a is associated with susceptibility of esophageal squamous cell carcinoma risk in Chinese Han. – Biomarkers 15: 614-618.
Yoon, K.A., Yoon, H., Park, S., Jang, H.J., Zo, J.I., Lee, H.S. and Lee, J.S. 2012. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer. – J. Thorac. Cardiovasc. Surg. 144: 794- 780.